Andrew E. Place, Md

This early-stage study tests a drug called venetoclax combined with standard chemotherapy in 30 children, teens, and young adults with high-risk blood cancers like leukemia and myelodysplastic syndrome. The goal is to find the safest dose and understand side effects. Participants…